breastfeeding or discard breast milk accumulated in the 4 hours following glucocorticoid administration. We conditionally recommend treatment with azathioprine/6-mercaptopurine, calcineurin inhibitors, NSAIDs and the non-TNF inhibitor biologic agents (anakinra, rituximab, belimumab, abatacept, tocilizumab, secukinumab, and ustekinumab) as compatible with breastfeeding We strongly recommend against use of CYC, leflunomide, MMF, and thalidomide while breastfeeding. We conditionally recommend against use of MTX while breastfeeding. Despite minimal passage of MTX into breast milk, especially with once-weekly dosing, this medication may accumulate in neonatal tissues DISCUSSION Patients' reproductive health concerns are relevant for all practicing rheumatologists. Issues regarding contraception, fertility, pregnancy, lactation, and the offspring's health affect almost every patient across all RMD diagnoses. The importance of this area is highlighted by recent publications that have